1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Combination of Hemogram Indexes to Predict Exacerbation in Stable Chronic Obstructive Pulmonary Disease

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background: Chronic obstructive pulmonary disease (COPD) is characterized by pulmonary and systemic inflammatory processes, and exacerbation of COPD represents a critical moment in the progression of COPD. Several biomarkers of inflammation have been proposed to have a predictive function in acute exacerbation. However, their use is still limited in routine clinical practice. The purpose of our study is to explore the prognostic efficacy of novel inflammatory hemogram indexes in the exacerbation among stable COPD patients.

          Method: A total of 275 stable COPD patients from the Shanghai COPD Investigation Comorbidity Program were analyzed in our study. Blood examinations, especially ratio indexes like platelet–lymphocyte ratio (PLR), platelet × neutrophil/lymphocyte ratio [systemic immune-inflammation index (SII)], and monocyte × neutrophil/lymphocyte ratio [systemic inflammation response index (SIRI)], lung function test, CT scans, and questionnaires were performed at baseline and routine follow-ups. Clinical characteristics and information of exacerbations were collected every 6 months. The relationship between hemogram indexes and diverse degrees of exacerbation was assessed by logistic regression. The receiver operating characteristic (ROC) curve and area under the curve (AUC) were used to evaluate the ability of hemogram indexes to predict exacerbation of COPD. Furthermore, the discrimination and accuracy of combined indexes were measured by ROC and calibration curve.

          Result: There was a significant positive correlation between PLR levels and total exacerbation of COPD patients in a stable stage in a year. Also, the predictive ability of PLR exceeded any other ratio indexes, with an AUC of 0.66. SII and SIRI ranked second only to PLR, with an AUC of 0.64. When combining PLR with other indexes (sex, COPD year, and St. George's Respiratory Questionnaire scores), they were considered as the most suitable panel of index to predict total exacerbation. Based on the result of the ROC curve and calibration curve, the combination shows optimal discrimination and accuracy to predict exacerbation events in COPD patients.

          Conclusion: The hemogram indexes PLR, SII, and SIRI were associated with COPD exacerbation. Moreover, the prediction capacity of exacerbation was significantly elevated after combining inflammatory hemogram index PLR with other indexes, which will make it a promisingly simple and effective marker to predict exacerbation in patients with stable COPD.

          Related collections

          Most cited references37

          • Record: found
          • Abstract: found
          • Article: not found

          Cellular and molecular mechanisms of asthma and COPD.

          Asthma and chronic obstructive pulmonary disease (COPD) both cause airway obstruction and are associated with chronic inflammation of the airways. However, the nature and sites of the inflammation differ between these diseases, resulting in different pathology, clinical manifestations and response to therapy. In this review, the inflammatory and cellular mechanisms of asthma and COPD are compared and the differences in inflammatory cells and profile of inflammatory mediators are highlighted. These differences account for the differences in clinical manifestations of asthma and COPD and their response to therapy. Although asthma and COPD are usually distinct, there are some patients who show an overlap of features, which may be explained by the coincidence of two common diseases or distinct phenotypes of each disease. It is important to better understand the underlying cellular and molecular mechanisms of asthma and COPD in order to develop new treatments in areas of unmet need, such as severe asthma, curative therapy for asthma and effective anti-inflammatory treatments for COPD.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Prognostic Value of Preoperative Systemic Immune-Inflammation Index in Patients with Cervical Cancer

            The systemic immune-inflammation index (SII) based on peripheral lymphocyte, neutrophil and platelet counts has been considered a good index that reflects the local immune response and systemic inflammation. However, the use of the SII has not been reported in cervical cancer. In this study, Kaplan-Meier survival analysis showed that a high SII was associated with poor prognosis in cervical cancer patients in the primary and validation cohorts. A higher SII had a significant correlation with larger tumours but had no correlation with other clinicopathological parameters. Among all systemic immune indexes, the SII is the only independent prognostic factor for cervical cancer patients. Compared with the area under the curve for the neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and monocyte/lymphocyte ratio (MLR), the area for the SII was larger at 3 and 5 years. In addition, the SII still retains it prognostic values across all FIGO stages. The SII can independently predict the overall survival of patients with cervical cancer receiving radical resection and is thus superior to existing systemic inflammatory indexes. The prognostic nomogram based on the SII is a reliable model for predicting the postoperative survival of patients with cervical cancer.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.

              This document provides clinical recommendations for treatment of chronic obstructive pulmonary disease (COPD) exacerbations.Comprehensive evidence syntheses, including meta-analyses, were performed to summarise all available evidence relevant to the Task Force's questions. The evidence was appraised using the Grading of Recommendations, Assessment, Development and Evaluation approach and the results were summarised in evidence profiles. The evidence syntheses were discussed and recommendations formulated by a multidisciplinary Task Force of COPD experts.After considering the balance of desirable and undesirable consequences, quality of evidence, feasibility, and acceptability of various interventions, the Task Force made: 1) a strong recommendation for noninvasive mechanical ventilation of patients with acute or acute-on-chronic respiratory failure; 2) conditional recommendations for oral corticosteroids in outpatients, oral rather than intravenous corticosteroids in hospitalised patients, antibiotic therapy, home-based management, and the initiation of pulmonary rehabilitation within 3 weeks after hospital discharge; and 3) a conditional recommendation against the initiation of pulmonary rehabilitation during hospitalisation.The Task Force provided recommendations related to corticosteroid therapy, antibiotic therapy, noninvasive mechanical ventilation, home-based management, and early pulmonary rehabilitation in patients having a COPD exacerbation. These recommendations should be reconsidered as new evidence becomes available.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Med (Lausanne)
                Front Med (Lausanne)
                Front. Med.
                Frontiers in Medicine
                Frontiers Media S.A.
                2296-858X
                09 December 2020
                2020
                : 7
                : 572435
                Affiliations
                [1] 1Department of Respiratory and Critical Care Medicine, Huadong Hospital, Fudan University , Shanghai, China
                [2] 2Department of Respiratory and Critical Care Medicine, Changji Branch of First Affiliated Hospital of Xinjiang Medical University , Xinjiang, China
                [3] 3Department of Respiratory Medicine, Putuo People's Hospital , Shanghai, China
                [4] 4Department of Respiratory Medicine, Tongren Hospital, Shanghai Jiaotong University School of Medicine , Shanghai, China
                [5] 5Department of Respiratory Medicine Shanghai Pudong Hospital, Fudan University Pudong Medical Center , Shanghai, China
                [6] 6Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine , Shanghai, China
                [7] 7Department of Respiratory Medicine, Xinhua Hospital, Shanghai Jiaotong University School of Medicine , Shanghai, China
                [8] 8Department of Respiratory and Critical Care Medicine, Huashan Hospital, Fudan University , Shanghai, China
                [9] 9Baoshan District Hospital of Integrated Traditional Chinese and Western Medicine Hospital , Shanghai, China
                [10] 10Department of Respiratory Medicine, Shanghai Fifth's Hospital, Fudan University , Shanghai, China
                [11] 11Department of Respiratory Medicine, Pudong New District People's Hospital , Shanghai, China
                [12] 12Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University , Shanghai, China
                [13] 13Department of Pulmonary and Critical Care Medicine, Tongji Hospital, Tongji University School of Medicine , Shanghai, China
                [14] 14Department of Respiratory Medicine, Shanghai Ninth's Hospital, Shanghai Jiaotong University School of Medicine , Shanghai, China
                [15] 15Department of Respiratory and Critical Care Medicine, Zhongshan Hospital, Fudan University , Shanghai, China
                [16] 16Department of Respiratory and Critical Care Medicine, Changhai Hospital Affiliated to Navy Military Medical University , Shanghai, China
                Author notes

                Edited by: Yahong Chen, Peking University Third Hospital, China

                Reviewed by: Zhiyi He, Guangxi Medical University, China; Steven Huang, University of Michigan, United States

                *Correspondence: Huili Zhu zhuhuili001@ 123456126.com

                This article was submitted to Pulmonary Medicine, a section of the journal Frontiers in Medicine

                †These authors have contributed equally to this work

                Article
                10.3389/fmed.2020.572435
                7769039
                33381510
                26441da9-8315-4030-bc24-9b3985437024
                Copyright © 2020 Liu, Ge, Feng, Hang, Zhang, Jin, Bao, Zhou, Han, Li, Qian, Jie, Gu, Gao, Yu, Wang, Ji, Zhang and Zhu.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 14 June 2020
                : 30 September 2020
                Page count
                Figures: 5, Tables: 3, Equations: 0, References: 37, Pages: 10, Words: 6289
                Categories
                Medicine
                Original Research

                copd,hemogram index,plr,exacerbation,inflammation
                copd, hemogram index, plr, exacerbation, inflammation

                Comments

                Comment on this article